Baird Maintains Outperform on Cardinal Health, Lowers Price Target to $128
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Cardinal Health (NYSE:CAH) but lowers the price target from $134 to $128.
May 03, 2024 | 10:55 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird maintains an Outperform rating on Cardinal Health but lowers the price target from $134 to $128.
While the reduction in price target could suggest a slight adjustment in valuation expectations, the maintenance of an Outperform rating indicates continued confidence in the company's performance. This mixed signal might lead to a neutral short-term impact on the stock price as investors weigh the lowered price target against the positive rating.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100